On May 21, 2021 in an interview with Dr Byram Bridle, he revealed that Freedom of Information (FOIA) documents sourced from the Japanese Regulatory Agency revealed that the lipid nanoparticles (LNP) used in the new genetic mRNA COVID-19 vaccines does not stay at the injection site in the arm, as officials said, but infact travels through out the entire body of the mice test subjects in the animal biodistribution study. [1, 2]
Worse still, they accumulated with the highest concentrations in the ovaries of the mice, raising serious concerns over whether this could affect all aspects of fertility – when injected into child-baring-aged women and pregnant women.
These findings suggest that the SARS-CoV-2 synthetic, foreign spike protein could be made in any cell in the body of an injected person, and the consequences are completely unknown – or atleast not shared with the public.